Body weight management and safety with efpeglenatide in adults without diabetes: A phase II randomized study

Article Authors: Richard E Pratley, Jahoon Kang, Michael E Trautmann, Marcus Hompesch, OakPil Han, John Stewart, Christopher H Sorli, Stephan Jacob, Kun-Ho Yoon

About This Article

To evaluate the safety of efpeglenatide, a long-acting glucagon-like peptide-1 receptor agonist (GLP-1RA), and its effects on body weight management in adults without diabetes.

View Now
Body weight management and safety with efpeglenatide in adults without diabetes: A phase II randomized study thumbnail